<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011665'>Takotsubo cardiomyopathy</z:hpo> (also referred to as transient apical ballooning syndrome, <z:e sem="disease" ids="C1719470" disease_type="Disease or Syndrome" abbrv="">broken heart syndrome</z:e> or stress <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>) is an increasingly recognized entity in the western world typically characterized by reversible left ventricular dysfunction that develops in the setting of <z:hpo ids='HP_0011009'>acute</z:hpo> severe emotional or physical stress </plain></SENT>
<SENT sid="1" pm="."><plain>Increased <z:chebi fb="2" ids="33567">catecholamine</z:chebi> levels have been proposed to play a central role in the pathogenesis of the disease, although the specific pathophysiology of this condition remains elusive at the present moment </plain></SENT>
<SENT sid="2" pm="."><plain>In recent times, there have been reports of <z:hpo ids='HP_0011665'>takotsubo cardiomyopathy</z:hpo> (TC) following medical interventions such as invasive or surgical procedures or specific medical regimens </plain></SENT>
<SENT sid="3" pm="."><plain>In the current report, we present a patient with multiple recurrences of TC triggered by the same medical therapeutic intervention; in our particular case, repetitive exposure to inhaled beta-2-adrenoceptor <z:chebi fb="4" ids="48705">agonist</z:chebi> </plain></SENT>
</text></document>